Anti-TPBGL monoclonal antibody

Anti-TPBGL antibody for FACS & in-vivo assay

Target products collectionGo to TPBGL/TPBGL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1861-Ab-1/ GM-Tg-hg-MP1861-Ab-2Anti-Human TPBGL monoclonal antibodyHuman
GM-Tg-rg-MP1861-Ab-1/ GM-Tg-rg-MP1861-Ab-2Anti-Rat TPBGL monoclonal antibodyRat
GM-Tg-mg-MP1861-Ab-1/ GM-Tg-mg-MP1861-Ab-2Anti-Mouse TPBGL monoclonal antibodyMouse
GM-Tg-cynog-MP1861-Ab-1/ GM-Tg-cynog-MP1861-Ab-2Anti-Cynomolgus/ Rhesus macaque TPBGL monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1861-Ab-1/ GM-Tg-felg-MP1861-Ab-2Anti-Feline TPBGL monoclonal antibodyFeline
GM-Tg-cang-MP1861-Ab-1/ GM-Tg-cang-MP1861-Ab-2Anti-Canine TPBGL monoclonal antibodyCanine
GM-Tg-bovg-MP1861-Ab-1/ GM-Tg-bovg-MP1861-Ab-2Anti-Bovine TPBGL monoclonal antibodyBovine
GM-Tg-equg-MP1861-Ab-1/ GM-Tg-equg-MP1861-Ab-2Anti-Equine TPBGL monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1861-Ab-1/ GM-Tg-hg-MP1861-Ab-2; GM-Tg-rg-MP1861-Ab-1/ GM-Tg-rg-MP1861-Ab-2;
GM-Tg-mg-MP1861-Ab-1/ GM-Tg-mg-MP1861-Ab-2; GM-Tg-cynog-MP1861-Ab-1/ GM-Tg-cynog-MP1861-Ab-2;
GM-Tg-felg-MP1861-Ab-1/ GM-Tg-felg-MP1861-Ab-2; GM-Tg-cang-MP1861-Ab-1/ GM-Tg-cang-MP1861-Ab-2;
GM-Tg-bovg-MP1861-Ab-1/ GM-Tg-bovg-MP1861-Ab-2; GM-Tg-equg-MP1861-Ab-1/ GM-Tg-equg-MP1861-Ab-2
Products NameAnti-TPBGL monoclonal antibody
Formatmab
Target NameTPBGL
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-TPBGL benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species TPBGL VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP1861
    Target NameTPBGL
    Gene ID100507050,100503386,681316,695023,100688193,105260973,786625,111774336
    Gene Symbol and SynonymsEG245190,Gm4980,TPBGL
    Uniprot AccessionP0DKB5
    Uniprot Entry NameTPBGL_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000261594
    Target ClassificationN/A

    The target: TPBGL, gene name: TPBGL, also named as . Predicted to be involved in negative regulation of canonical Wnt signaling pathway. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.